{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T08:30:17Z","timestamp":1792917017475,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.vaccine.2006.12.058","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T12:20:12Z","timestamp":1169036412000},"page":"5577-5582","source":"Crossref","is-referenced-by-count":18,"title":["Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness"],"prefix":"10.1016","volume":"25","author":[{"given":"N. James","family":"MacLachlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udeni B.","family":"Balasuriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.12.058_bib1","series-title":"Veterinary Virology","author":"Murphy","year":"1999"},{"key":"10.1016\/j.vaccine.2006.12.058_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1051\/vetres:2004019","article-title":"Equine viral vaccines: the past, present and future","volume":"35","author":"Minke","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2006.12.058_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molmed.2006.03.007","article-title":"Gene-based vaccines: recent technical clinical advances","volume":"12","author":"Ulmer","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.vaccine.2006.12.058_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0749-0739(17)30094-9","article-title":"Factors influencing the international spread of equine diseases","volume":"16","author":"Timoney","year":"2000","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.vaccine.2006.12.058_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0749-0739(17)30127-X","article-title":"Equine vaccination","volume":"16","author":"Lunn","year":"2000","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.vaccine.2006.12.058_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2006.01.010","article-title":"Immune response to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus","volume":"111","author":"Holmes","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1128\/CDLI.11.6.1120-1129.2004","article-title":"Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses","volume":"11","author":"Jin","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.vaccine.2005.07.083","article-title":"Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist","volume":"24","author":"Konishi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.058_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/vr.158.6.185","article-title":"Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in New market developed respiratory disease","volume":"158","author":"Newton","year":"2006","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2006.12.058_bib10","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.vaccine.2006.02.030","article-title":"Vaccination against equine influenza: Quid novi?","volume":"24","author":"Paillot","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.058_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.vetimm.2006.02.007","article-title":"Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus","volume":"112","author":"Paillot","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib12","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1016\/j.vaccine.2006.01.062","article-title":"Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1)","volume":"24","author":"Goodman","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.058_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetimm.2006.01.008","article-title":"Use of DNA and recombinant canarypox viral (ALAC) vectors for equine herpes virus vaccination","volume":"111","author":"Minke","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib14","first-page":"3","article-title":"Isolation of a filterable agent causing arteritis of horses and abortion by mares. Its differentiation from the equine abortion (influenza) virus","volume":"47","author":"Doll","year":"1957","journal-title":"Cornell Vet"},{"key":"10.1016\/j.vaccine.2006.12.058_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0749-0739(17)30397-8","article-title":"Equine viral arteritis","volume":"9","author":"Timoney","year":"1993","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.vaccine.2006.12.058_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/01652176.1996.9694625","article-title":"Equine arteritis virus: a review of clinical features and management aspects","volume":"18","author":"Glaser","year":"1996","journal-title":"Vet Q"},{"key":"10.1016\/j.vaccine.2006.12.058_bib17","series-title":"Proceedings of the Eighth International Conference on Equine Infectious Diseases","first-page":"328","article-title":"Equids and equine semen: international trade vs. disease control","author":"Timoney","year":"1999"},{"key":"10.1016\/j.vaccine.2006.12.058_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0034-5288(18)30616-7","article-title":"Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion","volume":"41","author":"Timoney","year":"1986","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2006.12.058_bib19","first-page":"95","article-title":"The carrier state in equine arteritis virus infection in the stallion with specific emphasis on the venereal mode of virus transmission","volume":"35","author":"Timoney","year":"1987","journal-title":"J Rep Fertil Suppl"},{"key":"10.1016\/j.vaccine.2006.12.058_bib20","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2746\/042516403775467162","article-title":"Lateral transmission of equine arteritis virus among Lipizzaner stallions in South Africa","volume":"35","author":"Guthrie","year":"2003","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2006.12.058_bib21","first-page":"629","article-title":"Nidovirales: a new order comprising Coronaviridae and Arteriviridae","volume":"142","author":"Cavanagh","year":"1997","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib22","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JVI.65.6.2910-2920.1991","article-title":"Equine arteritis virus is not a togavirus but belongs to the coronavirus-like superfamily","volume":"65","author":"Den Boon","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1099\/0022-1317-79-5-961","article-title":"The molecular biology of arteriviruses","volume":"79","author":"Snijder","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib24","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1128\/JVI.69.8.4668-4674.1995","article-title":"The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers","volume":"69","author":"De Vries","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1128\/JVI.77.1.97-104.2003","article-title":"Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity","volume":"77","author":"Snijder","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.vetimm.2004.09.003","article-title":"The immune response to equine arteritis virus: potential lessons for other arteriviruses","volume":"102","author":"Balasuriya","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib27","first-page":"1218","article-title":"Pathologic features of horses given avirulent equine arteritis virus intramuscularly","volume":"42","author":"McCollum","year":"1981","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2006.12.058_bib28","first-page":"1501","article-title":"Stability of viability and immunizing potency of lyophilized, modified equine arteritis live-virus vaccine","volume":"42","author":"Harry","year":"1981","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2006.12.058_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2460\/ajvr.2003.64.779","article-title":"Differentiation of strains of equine arteritis virus of differing virulence to horses by growth in equine endothelial cells","volume":"64","author":"Moore","year":"2003","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2006.12.058_bib30","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1128\/JVI.77.15.8470-8480.2003","article-title":"Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain","volume":"77","author":"Castillo-Olivares","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-0934(00)00231-7","article-title":"Development and evaluation of ELISA procedures to detect antibodies against the major envelope (GL) protein of equine arteritis virus","volume":"90","author":"Nugent","year":"2000","journal-title":"J Virol Method"},{"key":"10.1016\/j.vaccine.2006.12.058_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1008175525254","article-title":"Large envelope glycoprotein and nucleocapsid protein of equine arteritis virus (EAV) induce an immune response in Balb\/c mice by DNA vaccination: strategy for developing a DNA vaccine against EAV infection","volume":"22","author":"Tobiasch","year":"2001","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2006.12.058_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1020109801925","article-title":"Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus","volume":"25","author":"Giese","year":"2002","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2006.12.058_bib34","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1128\/JVI.74.22.10623-10630.2000","article-title":"Expression of two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles","volume":"74","author":"Balasuriya","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib35","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0264-410X(01)00485-6","article-title":"Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses","volume":"20","author":"Balasuriya","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.058_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1051\/vetres:2004022","article-title":"West Nile virus infection of horses","volume":"35","author":"Castillo-Olivares","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2006.12.058_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0065-3527(03)61005-5","article-title":"West Nile virus: epidemiology and ecology in North America","volume":"61","author":"Komar","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2006.12.058_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3201\/eid0704.010401","article-title":"West Nile virus: a reemerging global pathogen","volume":"7","author":"Petersen","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.058_bib39","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3201\/eid0812.020234","article-title":"West Nile virus epidemic in horses, Tuscany region, Italy","volume":"8","author":"Autorino","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.058_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2746\/042516400777612080","article-title":"Clinical and neuropathological features of West Nile virus equine encephalomyelitis in Italy","volume":"32","author":"Cantile","year":"2000","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2006.12.058_bib41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3201\/eid0808.010486","article-title":"West Nile virus outbreak in horses, southern France, 2000: results of a serosurvey","volume":"8","author":"Durand","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.058_bib42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3201\/eid0704.010412","article-title":"Equine encephalitis, United States","volume":"7","author":"Ostlund","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.058_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2460\/javma.2004.225.267","article-title":"Outcome of equids with clinical signs of West Nile virus infection and factors associated with death","volume":"225","author":"Salazar","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2006.12.058_bib44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2460\/javma.2004.225.1084","article-title":"Evaluation of an outbreak of West Nile virus infection in horses: 569 cases (2002)","volume":"225","author":"Schuler","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2006.12.058_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2006.12.058_bib46","series-title":"Fields\u2019 virology","first-page":"991","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2001"},{"key":"10.1016\/j.vaccine.2006.12.058_bib47","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3201\/eid0704.010418","article-title":"The relationships between West Nile and Kunjin viruses","volume":"7","author":"Scherret","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.058_bib48","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2006.12.058_bib49","first-page":"221","article-title":"Recombinant canarypox virus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","author":"Minke","year":"2004","journal-title":"Arch Virol Suppl"},{"key":"10.1016\/j.vaccine.2006.12.058_bib50","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/104063870601800413","article-title":"Detection of antibodies to West Nile virus in equine sera using microsphere immunoassay","volume":"18","author":"Balasuriya","year":"2006","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2006.12.058_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1051\/vetres:2006045","article-title":"West Nile virus infection of a cohort of vaccinated and unvaccinated horses","volume":"38","author":"Gardner","year":"2007","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2006.12.058_bib52","series-title":"Infectious diseases of livestock","first-page":"1231","article-title":"African horse sickness","author":"Coetzer","year":"2004"},{"key":"10.1016\/j.vaccine.2006.12.058_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jhmas\/jrj002","article-title":"Veterinary immunology as colonial science: method and quantification in the investigation of horse sickness in South Africa, C. 1905\u20131945","volume":"61","author":"Gilfoyle","year":"2006","journal-title":"J Hist Med Allied Sci"},{"key":"10.1016\/j.vaccine.2006.12.058_bib54","first-page":"177","article-title":"New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles","volume":"14","author":"Roy","year":"1998","journal-title":"Arch Virol Suppl"},{"key":"10.1016\/j.vaccine.2006.12.058_bib55","first-page":"255","article-title":"Control and eradication of African horse sickness with vaccine","volume":"119","author":"Sanchez-Vizcaino","year":"2004","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2006.12.058_bib56","first-page":"139","article-title":"Immune responses in a horse inoculated with the VP2 gene of African horsesickness virus","volume":"66","author":"Romito","year":"1999","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2006.12.058_bib57","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1099\/0022-1317-77-9-2053","article-title":"Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer capsid protein VP2 provides protection against lethal AHSV challenge","volume":"77","author":"Roy","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib58","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(01)00445-5","article-title":"The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant","volume":"20","author":"Scanlen","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.058_bib59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/viro.1996.0304","article-title":"Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus type 4","volume":"220","author":"Stone-Marchat","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2006.12.058_bib60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrmicro1090","article-title":"Climate change and the recent emergence of bluetongue in Europe","volume":"3","author":"Purse","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2006.12.058_bib61","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.313.5791.1218a","article-title":"Emerging infectious diseases. During a hot summer, bluetongue virus invades northern Europe","volume":"313","author":"Enserink","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2006.12.058_bib62","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1439-0450.2005.00883.x","article-title":"VP2 segment sequence analysis of some isolates of bluetongue virus recovered in the Mediterranean Basin during the 1998\u20132003 outbreak","volume":"52","author":"Potgieter","year":"2005","journal-title":"J Vet Med B"},{"key":"10.1016\/j.vaccine.2006.12.058_bib63","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.vaccine.2006.08.025","article-title":"Recombinant canary pox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep","volume":"25","author":"Boone","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T19:37:27Z","timestamp":1587325047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":63,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0264410X07000047"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.12.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}